Phase 1b Portion of the ACTION-1 Phase 1b/3 Trial of RYZ101 in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Progressing after 177 Lu Somatostatin Analogue (SSA) Therapy: Safety and Efficacy Findings.
Journal of Clinical Oncology(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要